Poll
Is "curing" aging really worth the risk of unforeseen evolutionary consequences?
As biotech breakthroughs like CRISPR and senolytics accelerate, the ethical debate over halting aging intensifies amid fears of unintended genetic ripple effects. Cast your vote on whether the promise of longevity outweighs the evolutionary gamble.
Options
Live results
Vote first to see results.
Emoji reactions
No reaction selected.
Comments
Please sign in to comment.
Share / embed
Quick info
- How do I vote in the "Is "curing" aging really worth the risk of unforeseen evolutionary consequences?" poll?
- Select one option on the page to cast your vote; results update with community votes in real time.
- Can I view results without voting?
- Yes. Use the "I don't know / Show results" option, or access the results summary after voting.
Similar polls
Up to 10 suggestions from the same category and shared tags, sorted by vote count; this poll is excluded.
From the same category
Basic Sciences and BiotechnologyThe same site category as this poll.
- Would you switch from E. coli to yeast expression systems for higher protein yield?
- Can gene editing really fix our food supply as climate change worsens?
- Is CRISPR-based editing too reckless for human trials, or are ethical fears holding back a revolution?
- Is synthetic biology overhyped or the next big thing in basic sciences?
- Have peer-reviewed papers become a popularity contest for novel results rather than a reliable foundation for reproducible science?
- Do synthetic biology startups add real value, or mostly hype hoping for a patent sell-off?
- Should we embrace dangerous gain-of-function research or is the pandemic risk too high to justify it?
- Are "natural" biotech products safer, or is that just a marketing lie?
- Do you trust AI-generated drug candidates more than those from traditional screening methods?
- Would you still trust a biotech startup over Big Pharma for new vaccines?
TrendVersus.com · live data